Moebius Medical Announces Dosing of First Patient in Global Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain ...Middle East

TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Israel-based Moebius Medical today announced that the first patient has been dosed in its Phase IIb clinical trial of MM-II, a novel candidate for the treatment of pain in knee osteoarthritis (OA). The Phase IIb clinical trial, which is...

Hence then, the article about moebius medical announces dosing of first patient in global phase iib clinical trial of mm ii a novel treatment for knee osteoarthritis pain was published today ( Tuesday 16/02/2021 - 07:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moebius Medical Announces Dosing of First Patient in Global Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain )

Also on site :

• Here's How I Eat Gluten-Free at Disney World and Miss Nothing
• Has social justice become the new religion of the West?
• Long-Running 1977 Romantic Comedy TV Series Still Ranks Among the Best Ever